Extended interval BNT162b2 vaccination enhances peak antibody generation in older people

H Parry, R Bruton, C Stephens, K Brown, G Amirthalingam, B Hallis, A Otter, J Zuo, P Moss
doi: https://doi.org/10.1101/2021.05.15.21257017

Article Information

doi 
https://doi.org/10.1101/2021.05.15.21257017
History 
  • May 17, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. H Parry1,
  2. R Bruton1,
  3. C Stephens1,
  4. K Brown2,
  5. G Amirthalingam2,
  6. B Hallis3,
  7. A Otter3,
  8. J Zuo1 and
  9. P Moss1,*
  1. 1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham. B15 2TT, UK
  2. 2National infection Service, Public Health England, Colindale, London NW9 5EQ, UK
  3. 3National infection Service, Public Health England, Porton Down, Salisbury, SP4 OJG, UK
  1. ↵*Corresponding author; email: p.moss{at}bham.ac.uk
Back to top
Posted May 17, 2021.
Download PDF
Data/Code
Email
Extended interval BNT162b2 vaccination enhances peak antibody generation in older people
H Parry, R Bruton, C Stephens, K Brown, G Amirthalingam, B Hallis, A Otter, J Zuo, P Moss
medRxiv 2021.05.15.21257017; doi: https://doi.org/10.1101/2021.05.15.21257017
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area